Braile Biomédica

Português Inglês Espanhol
The focus and determination of Braile Biomédica to be at the forefront of medical science have rewarded us with important achievements that reinforce our position of an innovative company in the market. In an unprecedented feat in 2010, Braile Biomédica had approved four projects at once in a FINEP Announcement, in the Innovation Economic Subvention program. The projects include the areas of Cardiac Surgery, Endovascular Surgery and Oncology. We are still in a very restricted group in the world that dedicates to the advanced study of endovascular product line, one of the strongest trends in medicine.